Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJ3RF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,301
Award facts
- Contract value 100% obligated
- $22,301.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials under a firm fixed-price contract valued at $22,301.16, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside delivery order was issued on August 5, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Renflexis is a biosimilar medication used to treat various inflammatory conditions and autoimmune diseases, representing a critical pharmaceutical commodity within the military healthcare supply chain.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive procurement vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages its extensive product portfolio and supply chain capabilities to fulfill the Defense Logistics Agency's diverse medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJ3RF?
SPE2DB25FJ3RF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FJ3RF worth?
The government has obligated $22,301 on SPE2DB25FJ3RF.
Is contract SPE2DB25FJ3RF an order under another contract?
Yes. SPE2DB25FJ3RF is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ3RF competed?
The extent of competition for SPE2DB25FJ3RF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award